Your session is about to expire
← Back to Search
Behavioural Intervention
n-of-1 trial guided clinical decision making for High Blood Pressure
N/A
Waitlist Available
Led By Joyce P Samuel, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 6 months
Awards & highlights
Study Summary
This study is evaluating whether a clinical trial can help improve blood pressure control in children with CKD and ESRD.
Eligible Conditions
- High Blood Pressure
- Chronic Kidney Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in 24-hour Mean Arterial Pressure (MAP)
Secondary outcome measures
Number of Participants With Target Blood Pressure
Trial Design
1Treatment groups
Experimental Treatment
Group I: n-of-1 trial guided clinical decision makingExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
n-of-1 trial guided clinical decision making
2021
N/A
~10
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,951 Total Patients Enrolled
Children's Hospital of PhiladelphiaOTHER
708 Previous Clinical Trials
8,581,050 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,359 Previous Clinical Trials
4,314,582 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger